Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

BACKGROUND: Management of severe symptomatic immune-related adverse events (IrAEs) related to immune checkpoint inhibitors (ICIs) can be facilitated by timely detection. As patients face a heterogeneous set of symptoms outside the clinical setting, remotely monitoring and assessing symptoms by using...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva Lopes, André Manuel, Colomer-Lahiguera, Sara, Darnac, Célia, Giacomini, Stellio, Bugeia, Sébastien, Gutknecht, Garance, Spurrier-Bernard, Gilliosa, Cuendet, Michel, Muet, Fanny, Aedo-Lopez, Veronica, Mederos, Nuria, Michielin, Olivier, Addeo, Alfredo, Latifyan, Sofiya, Eicher, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620631/
https://www.ncbi.nlm.nih.gov/pubmed/37851498
http://dx.doi.org/10.2196/48386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620631/
https://www.ncbi.nlm.nih.gov/pubmed/37851498
http://dx.doi.org/10.2196/48386

Ejemplares similares